FDA Updates Boxed Warning of Benzodiazepines, Adding Risks for Abuse & Addiction
The FDA is requiring all benzodiazepines to carry an updated boxed warning that addresses the risks of misuse, abuse and addiction associated with their use.
Source: The Rheumatologist - Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Drug Updates Safety abuse Addiction benzodiazepines FDA safety warning U.S. Food and Drug Administration (FDA) Source Type: research
More News: Addiction | Food and Drug Administration (FDA) | Rheumatology | Substance Abuse | Warnings